Merck (MRK.N): Third-quarter global sales were $17.28 billion, exceeding market expectations of $16.96 billion. Full-year 2025 global sales are projected to be between $64.5 billion and $65 billion, largely in line with market expectations. Adjusted

2025-10-30

Merck (MRK.N): Third-quarter global sales were $17.28 billion, exceeding market expectations of $16.96 billion. Full-year 2025 global sales are projected to be between $64.5 billion and $65 billion, largely in line with market expectations. Adjusted earnings per share for full-year 2025 are projected to be between $8.93 and $8.98, slightly higher than the market estimate of $8.91.